Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03443856 |
| Title | Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence (VESTIGE) |
| Acronym | VESTIGE |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | European Organisation for Research and Treatment of Cancer - EORTC |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | POL | NOR | ITA | ISR | GBR | FRA | ESP | DEU | CZE |